Search
for

    Sort by

    Research 931–960 of 1000+

    1. Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program SKIN The Journal of Cutaneous Medicine · 2025
    2. Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program American journal of clinical dermatology · 2024
    3. Cutaneous Adverse Drug Reactions to Antibiotics: How Much is the Extent of the Problem? JOJ dermatology & cosmetics · 2023
    4. Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children Frontiers in immunology · 2024
    5. ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW International Journal of Innovative Technologies in Social Science · 2025
    6. Adverse Reactions to Oral Retinoids An Update Drug Safety · 1993 · 53 citations
    7. Image3_Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network.TIFF OPAL (Open@LaTrobe) (La Trobe University) · 2021
    8. Faculty Opinions recommendation of Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2015
    9. Prospective Study on the Short-Term Adverse Effects From Gamma Knife Radiosurgery International journal of radiation oncology, biology, physics · 2007 · 1 citations
    10. Efficacy and Tolerability of a Hyaluronic Acid-Based Extracellular Matrix for Labia Majora Rejuvenation and Augmentation: A Pilot Study Curēus · 2024
    11. Non-clinical safety evaluation and risk assessment to human of aleglitazar, a dual PPAR α/γ agonist, and its major human metabolite Regulatory toxicology and pharmacology · 2017 · 3 citations
    12. HAIR LOSS ASSOCIATED WITH ESCITALOPRAM: DO SSRIs AFFECT MELATONIN AT THE HAIR FOLLICLE? Psychiatria Danubina · 2021
    13. Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date Drugs in context · 2023
    14. Neonatal derived mesenchymal stem cell mesotherapy in androgenetic alopecia: a retrospective observational study and review of literature International Journal of Scientific Reports · 2015 · 2 citations
    15. Minoxidil Elsevier eBooks · 2015
    16. Efficacy of Activated 3X Platelet-Rich Plasma in the Treatment of Androgenic Alopecia. PubMed · 2017 · 3 citations
    17. Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update Drug design, development and therapy · 2021 · 20 citations
    18. Efficacy of platelet-rich plasma in treatment of androgenic alopecia Asian Journal of Transfusion Science · 2015 · 74 citations
    19. A Prospective interventional study on the therapeutic potential of human placental extract in dermatological conditions. 2025
    20. PREVENTION AND TREATMENT OF CHEMOTHERAPY-INDUCED ALOPECIA: A NARRATIVE REVIEW ON EMERGING TECHNIQUES International Journal of Health Science · 2024
    21. Growth Factors and Microneedling in Alopecia Areata: A Narrative Review Skin appendage disorders · 2024
    22. Efficacy and Safety of DR SKS Hair Growth Booster Serum in Adult Male and Female with Androgenic Alopecia 2023
    23. Efficacy of Platelet Rich Plasma in Treatment of Androgenic Alopecia Hematology & Transfusion International Journal · 2016
    24. Research Article Neonatal derived mesenchymal stem cell mesotherapy in androgenetic alopecia: a retrospective observational study and review of literature 2015
    25. The Efficacy and Safety of Dr. SKS Hair Booster Serum (a Cocktail of Micronutrients and Multivitamins) in Adult Males and Females With Androgenetic Alopecia: An Open-Label, Non-randomized, Prospective Study Cureus · 2023
    26. Understanding of a Veiled Illness: Evaluation of Polycystic Ovarian Syndrome awareness (PCOS) in Young Female Students of Karachi. BioSight · 2022
    27. ESCITALOPRAM 2004
    28. MP89-08 POST-FINASTERIDE SYNDROME: REAL OR IMAGINED? The Journal of Urology · 2016 · 2 citations
    29. A Single-Arm, Open-Label, Phase Ib Clinical Study Evaluating the Efficacy and Safety of Durvalumab in Combination with Albumin-Bound Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable Stage III Non-Small Cell Lung Cancer Recent Patents on Anti-Cancer Drug Discovery · 2025
    30. Treatment of Del(5q) Myelodysplastic Syndrome with All-Trans-Retinoic Acid and Tocopherol-α. Blood · 2004